The better we understand cellular processes such as RNA regulation, the better molecular therapies can be developed. Until now, it has been especially difficult to track the regulation of non-coding RNA, which is RNA that is not further converted into proteins. A research team from the Tech ... more
Prof. Dr. Thomas Brück
Technische Universität München, Werner Siemens-Lehrstuhl für Synthetische Biotechnologie
Thomas Brück, born in 1972, obtained his B.Sc. in chemistry, biochemistry and management science from Keele University, Stoke on Trent. Additionally, he holds an M.Sc. in molecular medicine from the same institution. In 2002, Thomas obtained his Ph.D. in Protein Biochemistry from Imperial College and Greenwich University, London. From 2002 to 2006 Dr. Brück held an assistance professorship in marine proteomics and biocatalysis at the Center of Excellence for Marine Biotechnology and Biomedicine at Florida Atlantic University (Boca Raton), focusing on bioactive natural product biosynthesis in marine macroorganisms. In 2006 Thomas Brück returned to Germany and joined Süd-Chemie AG (now Clariant Produkte Deutschland GmbH), where he held various management positions in the central R&D unit Biotechnology. Since 2011 Thomas Brück has been a tenured full professor at the Technical University of Munich (TUM). He holds the Werner Siemens-Chair of Synthetic Biotechnology and is Director of the TUM AlgaeTech Center. The research activities of his chair are focused around the isolation and development of sustainable biocatalytic processes, which enable conversion of greenhouse gases and biogenic residue streams into value adding products for the food, chemical and pharmaceutical industries
Sustainability without economical and ecological compromises so we can pass on planet worth living to future generations.
The research of the Brück group is centered around the isolation and process oriented optimization of enzymes and whole cell biocatalysts by combining synthetic and systems biology with innovative methods in bioinformatics and bioprocess engineering. The activities aim to generate process-tailored biocatalysts that are embedded in mass and energy efficient biorefinery settings and allow direct conversion of greenhouse gases and biomass residue streams into sustainable, value adding products for the chemical, food and pharmaceutical sectors.
The innovative research of the Brück group was cited in the IPCC world climate report 1.5 as industrial routes for a net CO2 sink. In reference to the IPCC report the NGO “European Business Council for Sustainable energy” (www.e5.org) awarded the e-ward 2018 to Prof. Brück. To honor the diverse sustainability innovations driven forward by Professor Brück, he received the first TUM sustainability award in 2019. Since 2020 Professor Brück has been an elected member of the German Bioeconomy Council, where he provides advice to the federal government on all sustainability matters.
The Werner Siemens Chair of Synthetic Biotechnology focuses on the development of biocatalytic systems for sustainable material transformations based on urban biomass residue streams.
- Synthetic and systems biology
- Genetic manipulation of microbial systems
- Algae biotechnology
- Circular biorefinery concepts